A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A; IRC-005
Administered By
Contributors
- Bandarenko III, Nicholas Co Investigator
- Ozment, Caroline Pinson Principal Investigator
Start/End
- October 16, 2015 - June 30, 2019